Symptom relief by traditional Chinese medicine at a Chinese medicine ward for head and neck cancer patients undergoing radiotherapy

The efficacy of integrated traditional Chinese medicine intervention at a Chinese medicine ward for head and neck cancer patients undergoing radiotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN32748291

Enrollment

120

Registered

2016-03-01

Start date

2013-03-11

Completion date

Unknown

Last updated

2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute toxicities post radiotherapy for head and neck cancers Cancer

Interventions

Patients choose to be in the study group or the control group according to their wishes. The study group are admitted to the Chinese medicine ward, Chang Gung Memorial Hospital, Taoyuan, Taiwan, and r

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients aged from 20 to 75 years old diagnosed with head and neck cancer and receiving radiotherapy with or without chemotherapy 2. Stable vital signs 3. Eastern Cooperative Oncology Group (ECOG) 0-2

Exclusion criteria

Exclusion criteria: 1. Cancer in terminal stage when aggressive treatments are not suitable 2. Unstable vital signs 3. ECOG performance ?3 4. Impaired renal and liver function at initial diagnosis (including chronic kidney disease stage III, IV, V and AST, ALT ? 5?upper normal limit) 5. Patients who have uncontrolled psychiatric problems or unclear consciousness 6. Patients who are receiving other Chinese medicine treatments

Design outcomes

Primary

Measure	Time frame
1. EORTC QLQ – H&N35 once per week since the second week of radiotherapy till the end 2. RTOG acute radiation morbidity scoring criteria measured at the first week, the fourth week and the end of radiotherapy	—

Secondary

Measure	Time frame
1. EORTC QLQ-C30 (version 3.0) measured at first, second, fourth and the end of radiotherapy 2. Body Constitution Questionanaire measured at first, second, fourth and the end of radiotherapy 3. Body weight per week since the first week of radiotherapy till the end 4. CBC/DC, AST, ALT, BUN, Cr, Albumin, High-sensitivity CRP, SCC of hospitalized patients at the beginning and the end of traditional Chinese medicine intervention	—

Measure

Time frame

1. EORTC QLQ-C30 (version 3.0) measured at first, second, fourth and the end of radiotherapy 2. Body Constitution Questionanaire measured at first, second, fourth and the end of radiotherapy 3. Body weight per week since the first week of radiotherapy till the end 4. CBC/DC, AST, ALT, BUN, Cr, Albumin, High-sensitivity CRP, SCC of hospitalized patients at the beginning and the end of traditional Chinese medicine intervention

—

Countries

Taiwan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026